nVent Electric PLC (NVT)vsVertex Pharmaceuticals Inc (VRTX)
NVT
nVent Electric PLC
$173.39
+2.02%
INDUSTRIALS · Cap: $28.04B
VRTX
Vertex Pharmaceuticals Inc
$448.29
+3.01%
HEALTHCARE · Cap: $107.87B
Smart Verdict
WallStSmart Research — data-driven comparison
Vertex Pharmaceuticals Inc generates 182% more annual revenue ($12.22B vs $4.33B). VRTX leads profitability with a 35.5% profit margin vs 11.4%. NVT appears more attractively valued with a PEG of 1.76. VRTX earns a higher WallStSmart Score of 66/100 (B-).
NVT
Buy55
out of 100
Grade: C-
VRTX
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-72.1%
Fair Value
$65.53
Current Price
$173.39
$107.86 premium
Margin of Safety
+56.6%
Fair Value
$989.67
Current Price
$448.29
$541.38 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 53.5% year-over-year
Keeps 36 of every $100 in revenue as profit
Strong operational efficiency at 38.1%
Earnings expanding 61.4% YoY
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 24 in profit
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Earnings declined 59.5%
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : NVT
The strongest argument for NVT centers on Revenue Growth. Revenue growth of 53.5% demonstrates continued momentum.
Bull Case : VRTX
The strongest argument for VRTX centers on Profit Margin, Operating Margin, EPS Growth. Profitability is solid with margins at 35.5% and operating margin at 38.1%.
Bear Case : NVT
The primary concerns for NVT are PEG Ratio, P/E Ratio, EPS Growth. A P/E of 58.8x leaves little room for execution misses.
Bear Case : VRTX
The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
NVT profiles as a growth stock while VRTX is a mature play — different risk/reward profiles.
NVT carries more volatility with a beta of 1.32 — expect wider price swings.
NVT is growing revenue faster at 53.5% — sustainability is the question.
VRTX generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
VRTX scores higher overall (66/100 vs 55/100), backed by strong 35.5% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
nVent Electric PLC
INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA
nVent Electric plc designs, manufactures, markets, installs and services electrical connection and protection products in the United States, Canada, Western and Eastern Europe included in the European Union, China, Eastern Europe not included in the European Union, America Latin, Middle East, Southeast Asia, Australia and Japan. The company is headquartered in London, the United Kingdom.
Vertex Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Compare with Other ELECTRICAL EQUIPMENT & PARTS Stocks
Want to dig deeper into these stocks?